mhurhangee/ep-ind-claims huggingface dataset:
A ring member (5, 5a, 5b) used for a connecting part of an electrical conduit (40a-c); wherein the ring member (5, 5a, 5b) includes a reduced diameter part at one end part thereof, a plurality of first click parts and a plurality of second click parts, the first and second click parts being provided side by side separately with slits therebetween to the reduced diameter part in the circumferential direction of the ring member (5, 5a, 5b); characterized in that the ring member (5, 5a, 5b) is in substantially C shape with an opening at a part of a circumferential direction of the ring member (5, 5a, 5b); the first click part is a click part that protrudes from the reduced diameter part substantially parallel to the pipe axial direction to form a slide guide; and the second click part is a locking click whose outer diameter gradually increases from the reduced diameter part toward a tip end on a cross section taken in the pipe axial direction thereof. wherein the ring member (5, 5a, 5b) includes a reduced diameter part at one end part thereof, a plurality of first click parts and a plurality of second click parts, the first and second click parts being provided side by side separately with slits therebetween to the reduced diameter part in the circumferential direction of the ring member (5, 5a, 5b); characterized in that the ring member (5, 5a, 5b) is in substantially C shape with an opening at a part of a circumferential direction of the ring member (5, 5a, 5b); the first click part is a click part that protrudes from the reduced diameter part substantially parallel to the pipe axial direction to form a slide guide; and the second click part is a locking click whose outer diameter gradually increases from the reduced diameter part toward a tip end on a cross section taken in the pipe axial direction thereof.
A mesh structure in the form of a gauze, net, cloth, screen, grid or fabric on to which one or more chemical, physical or biologically active agents are provided comprising: - WHO-recommended insecticides effective against mosquitoes and other flying insects, and/or - insecticides from other insecticide classes than recommended by WHO, and/or - an insect growth regulator effective against larvae and/or adults, such as pyriproxyfen effective against mosquitoes, and/or - an insect-killing fungus, such as Beauveria bassiana, and/or Metarhizium anisopliae, and/or - an intensifying agent, such as non-synthetic or synthetic silica, or diatomaceous earth which affects the insect exoskeleton, notably the cuticula, and that the mesh structure is coated with an electrostatic coating in the form of a platinum complex-containing silicone composition whereon said one or more agents are provided. - WHO-recommended insecticides effective against mosquitoes and other flying insects, and/or - insecticides from other insecticide classes than recommended by WHO, and/or - an insect growth regulator effective against larvae and/or adults, such as pyriproxyfen effective against mosquitoes, and/or - an insect-killing fungus, such as Beauveria bassiana, and/or Metarhizium anisopliae, and/or - an intensifying agent, such as non-synthetic or synthetic silica, or diatomaceous earth which affects the insect exoskeleton, notably the cuticula, and
A non-woven textile comprising: a first layer formed from a plurality of first filaments that include a first thermoplastic polymer material with a first melting temperature; and a second layer located adjacent to the first layer and secured to the first layer, the second layer being formed from plurality of second filaments that include a second thermoplastic polymer material with a second melting temperature, the first melting temperature being lower than the second melting temperature wherein the first layer includes a fused region having a continuous area of at least one square centimeter, the first filaments being fused to form a non-filamentous portion of the non-woven textile in the fused region, and the second layer includes a filamentous region adjacent to the fused region of the first layer. a first layer formed from a plurality of first filaments that include a first thermoplastic polymer material with a first melting temperature; and a second layer located adjacent to the first layer and secured to the first layer, the second layer being formed from plurality of second filaments that include a second thermoplastic polymer material with a second melting temperature, the first melting temperature being lower than the second melting temperature wherein the first layer includes a fused region having a continuous area of at least one square centimeter, the first filaments being fused to form a non-filamentous portion of the non-woven textile in the fused region, and the second layer includes a filamentous region adjacent to the fused region of the first layer.
Insulin and glucagon for use in a method of treating a subject, wherein the insulin and glucagon are to be co-administered at an insulin:glucagon molar ratio between about 1:1 and about 6:1, wherein the insulin and glucagon are to be administered in an amount therapeutically effective to simultaneously treat or inhibit hyperglycemia and to inhibit hypoglycemia in a subject having type-1 diabetes mellitus, wherein co-administering the insulin and glucagon comprises administering the insulin at a basal infusion rate of about 0.2-0.6 mU/kg/minute and administering the glucagon at a basal infusion rate of about 1-4 ng/kg/minute, and wherein the insulin includes the hormone insulin and/or any one or more insulin analogues and the glucagon includes the hormone glucagon and/or one or more glucagon analogues. wherein the insulin and glucagon are to be administered in an amount therapeutically effective to simultaneously treat or inhibit hyperglycemia and to inhibit hypoglycemia in a subject having type-1 diabetes mellitus, wherein co-administering the insulin and glucagon comprises administering the insulin at a basal infusion rate of about 0.2-0.6 mU/kg/minute and administering the glucagon at a basal infusion rate of about 1-4 ng/kg/minute, and wherein the insulin includes the hormone insulin and/or any one or more insulin analogues and the glucagon includes the hormone glucagon and/or one or more glucagon analogues.
A compound of Formula I, which is at least one of: a salt of biguanide with RH or its pharmaceutically acceptable solvate, polymorph, enantiomer, stereoisomer or hydrate; and a mixture of biguanide or a pharmaceutically acceptable salt thereof, and RH or a pharmaceutically acceptable solvate, polymorph, enantiomer, stereoisomer or hydrate thereof, Wherein, R 1, R 2, R 3, R 4 are independently selected from the group consisting of H, D, CD 3 and CH 3; and RH is selected from the group consisting of and a salt of biguanide with RH or its pharmaceutically acceptable solvate, polymorph, enantiomer, stereoisomer or hydrate; and a mixture of biguanide or a pharmaceutically acceptable salt thereof, and RH or a pharmaceutically acceptable solvate, polymorph, enantiomer, stereoisomer or hydrate thereof, Wherein, R 1, R 2, R 3, R 4 are independently selected from the group consisting of H, D, CD 3 and CH 3; and RH is selected from the group consisting of and
A method of generating a low-pulsatility fluid flow, comprising: pumping a fluid into a first pressurized reservoir using a first peristaltic fluid pump; sensing an amount of the fluid in the first pressurized reservoir to create a first fluid quantity signal; in response to the first fluid quantity signal, maintaining a predetermined amount of the fluid in the first pressurized reservoir by pumping the fluid into the first pressurized reservoir and/or removing the fluid from the first pressurized reservoir using the first peristaltic fluid pump; pumping the fluid from the first pressurized reservoir to a second pressurized reservoir using a second peristaltic fluid pump; sensing an amount of the fluid in the second pressurized reservoir to create a second fluid quantity signal; in response to the second fluid quantity signal, maintaining a predetermined amount of the fluid in the second pressurized reservoir by pumping the sheath fluid into the second pressurized reservoir using the second peristaltic pump and/or removing the fluid from the second pressurized reservoir in response to the second sheath fluid quantity signal; supplying air to the first pressurized reservoir so as to pressurize the first pressurized reservoir; communicating air from the first pressurized reservoir to the second pressurized reservoir using a peristaltic air pump to pressurize air in the second reservoir to a predetermined air pressure; and maintaining the predetermined air pressure in the second reservoir by communicating air into the second pressurized reservoir using the peristaltic air pump. pumping a fluid into a first pressurized reservoir using a first peristaltic fluid pump; sensing an amount of the fluid in the first pressurized reservoir to create a first fluid quantity signal; in response to the first fluid quantity signal, maintaining a predetermined amount of the fluid in the first pressurized reservoir by pumping the fluid into the first pressurized reservoir and/or removing the fluid from the first pressurized reservoir using the first peristaltic fluid pump; pumping the fluid from the first pressurized reservoir to a second pressurized reservoir using a second peristaltic fluid pump; sensing an amount of the fluid in the second pressurized reservoir to create a second fluid quantity signal; in response to the second fluid quantity signal, maintaining a predetermined amount of the fluid in the second pressurized reservoir by pumping the sheath fluid into the second pressurized reservoir using the second peristaltic pump and/or removing the fluid from the second pressurized reservoir in response to the second sheath fluid quantity signal; supplying air to the first pressurized reservoir so as to pressurize the first pressurized reservoir; communicating air from the first pressurized reservoir to the second pressurized reservoir using a peristaltic air pump to pressurize air in the second reservoir to a predetermined air pressure; and maintaining the predetermined air pressure in the second reservoir by communicating air into the second pressurized reservoir using the peristaltic air pump.
A method performed by a base station in a wireless communication system, the method comprising: transmitting, to a terminal, channel state information, CSI, feedback configuration information instructing the terminal to transmit a feedback of a first precoding matrix indicator, PMI, for a first dimension and a channel quality indicator, CQI; transmitting, to the terminal, a reference signal; and receiving, from the terminal, feedback information including the first PMI for the first dimension and the CQI, wherein the first PMI indicating a precoding for the first dimension is based on the reference signal, wherein the CQI is determined based on the precoding for the first dimension and an assumption that precoding negotiated between the terminal and the base station for a second dimension is applied, and wherein the precoding for the second dimension is that each precoding for the second dimension, among a set of precoding candidates for the second dimension, is applied to each of a plurality of sub-bands of an entire band. transmitting, to a terminal, channel state information, CSI, feedback configuration information instructing the terminal to transmit a feedback of a first precoding matrix indicator, PMI, for a first dimension and a channel quality indicator, CQI; transmitting, to the terminal, a reference signal; and receiving, from the terminal, feedback information including the first PMI for the first dimension and the CQI, wherein the first PMI indicating a precoding for the first dimension is based on the reference signal, wherein the CQI is determined based on the precoding for the first dimension and an assumption that precoding negotiated between the terminal and the base station for a second dimension is applied, and wherein the precoding for the second dimension is that each precoding for the second dimension, among a set of precoding candidates for the second dimension, is applied to each of a plurality of sub-bands of an entire band.
A compound of formula wherein each R 1 is independently selected from the group consisting of halogen, -CN, -CF 3, -OCF 3, C 1-3 alkyl and C 1-3 alkoxy; t is 0, 1 or 2; ring A is selected from the group consisting of C 4-7 cycloalkylene, C 4-7 cycloalkenylene and 4-7 membered nitrogen-containing heterocyclylene, wherein said C 4-7 cycloalkylene, C 4-7 cycloalkenylene and 4-7 membered nitrogen-containing heterocyclylene is optionally substituted with one or more, identical or different substituent(s) selected from the group consisting of halogen, C 1-4 alkyl and oxo; G is selected from the group consisting of a bond, -NH-, -N(C 1-4 alkyl)- and -O-; LK is -U-V-W-, wherein U binds to G; U is selected from the group consisting of a bond, carbonyl, C 1-12 alkylene, C 6-10 arylene, 5-10 membered heteroarylene, -(CH 2) n O- and -O(CH 2) n -; V is selected from the group consisting of a bond, carbonyl, C 1-12 alkylene, C 6-10 arylene, 5-10 membered heteroarylene, -(CH 2) n O- and -O(CH 2) n -; W is selected from the group consisting of a bond, carbonyl, C 1-12 alkylene, C 6-10 arylene, 5-10 membered heteroarylene, -(CH 2) n O- and -O(CH 2) n -; wherein each of said C 6-10 arylene and of said 5-10 membered heteroarylene in U, V and W is optionally independently substituted with one to three, identical or different substituent(s) selected from the group consisting of halogen, C 1-4 alkyl, C 1-4 alkoxy and -CN; wherein at least one of U, V and W is different from the other two; wherein U and W are not -O- if V is -O-; each n is independently selected from 0 to 8; or a salt thereof. each R 1 is independently selected from the group consisting of halogen, -CN, -CF 3, -OCF 3, C 1-3 alkyl and C 1-3 alkoxy; t is 0, 1 or 2; ring A is selected from the group consisting of C 4-7 cycloalkylene, C 4-7 cycloalkenylene and 4-7 membered nitrogen-containing heterocyclylene, wherein said C 4-7 cycloalkylene, C 4-7 cycloalkenylene and 4-7 membered nitrogen-containing heterocyclylene is optionally substituted with one or more, identical or different substituent(s) selected from the group consisting of halogen, C 1-4 alkyl and oxo; G is selected from the group consisting of a bond, -NH-, -N(C 1-4 alkyl)- and -O-; LK is -U-V-W-, wherein U binds to G; U is selected from the group consisting of a bond, carbonyl, C 1-12 alkylene, C 6-10 arylene, 5-10 membered heteroarylene, -(CH 2) n O- and -O(CH 2) n -; V is selected from the group consisting of a bond, carbonyl, C 1-12 alkylene, C 6-10 arylene, 5-10 membered heteroarylene, -(CH 2) n O- and -O(CH 2) n -; W is selected from the group consisting of a bond, carbonyl, C 1-12 alkylene, C 6-10 arylene, 5-10 membered heteroarylene, -(CH 2) n O- and -O(CH 2) n -; wherein each of said C 6-10 arylene and of said 5-10 membered heteroarylene in U, V and W is optionally independently substituted with one to three, identical or different substituent(s) selected from the group consisting of halogen, C 1-4 alkyl, C 1-4 alkoxy and -CN; wherein at least one of U, V and W is different from the other two; wherein U and W are not -O- if V is -O-; each n is independently selected from 0 to 8; or a salt thereof.
An electromechanical surgical system, comprising: an end effector configured to perform at least one function; an adapter assembly being arranged for selectively interconnecting the end effector and a hand-held surgical instrument; a one-wire bidirectional serial communications interface extending through the end effector, the adapter assembly, and the hand-held surgical instrument; and the hand-held surgical instrument including an instrument housing (17,18,19) defining a connecting portion for selectively connecting with the adapter assembly; a master circuit coupled to the one-wire bidirectional serial communications interface and configured to identify or control the adapter assembly or the end effector; a power source coupled to the one-wire bidirectional serial communications interface and configured to provide power to the adapter assembly or the end effector; a first switch configured to connect the master circuit to the one-wire bidirectional serial communications interface; a second switch configured to connect the power source to the one-wire bidirectional serial communications interface; and a controller including a processor configured to control operation of the hand-held surgical instrument, the controller having a wake-up pin connected to the one-wire bidirectional serial communications interface, the wake-up pin is configured to receive a presence pulse from the end effector or the adapter. an end effector configured to perform at least one function; an adapter assembly being arranged for selectively interconnecting the end effector and a hand-held surgical instrument; a one-wire bidirectional serial communications interface extending through the end effector, the adapter assembly, and the hand-held surgical instrument; and the hand-held surgical instrument including an instrument housing (17,18,19) defining a connecting portion for selectively connecting with the adapter assembly; a master circuit coupled to the one-wire bidirectional serial communications interface and configured to identify or control the adapter assembly or the end effector; a power source coupled to the one-wire bidirectional serial communications interface and configured to provide power to the adapter assembly or the end effector; a first switch configured to connect the master circuit to the one-wire bidirectional serial communications interface; a second switch configured to connect the power source to the one-wire bidirectional serial communications interface; and a controller including a processor configured to control operation of the hand-held surgical instrument, the controller having a wake-up pin connected to the one-wire bidirectional serial communications interface, the wake-up pin is configured to receive a presence pulse from the end effector or the adapter.
A compound for use in the prevention and/or treatment of malaria, wherein said compound is selected from Alaremycin or a derivative thereof represented by formula: (wherein R 1 represents a hydroxy group, an amino group, or an unsubstituted straight chain or branched alkoxy group or alkylamino group having 1 to 8 carbons; R 2 represents hydrogen, a substituted or unsubstituted straight chain or branched alkyl group having 1 to 8 carbons, or a substituted or unsubstituted aromatic group having 4 to 10 carbons; and R 3 represents hydrogen or a methyl group), or a pharmaceutically acceptable salt thereof.
A nucleonic instrument for measuring a density or level of one or more material phases within a container, comprising:- (a) an array of sources of ionising radiation, (b) at least one detector probe for detecting ionising radiation comprising an array of radiation detectors mounted on a circuit board (12a, 12b), (c) a power source, and electronic apparatus comprising a control unit and a signal and data processing means for calculating a density profile of the material phases using signals generated by the detectors in response to radiation received from the radiation sources; the power source and electronic apparatus being housed within an enclosure supported mounted adjacent to the detector probe, characterised in that said circuit board (12a, 12b) comprises at least two portions (12a, 12b) each portion being aligned substantially parallel to the longitudinal axis of said array and each of said portions being in a different plane from each other portion, wherein one portion of said circuit board carries a high voltage circuit and a different potion of said circuit board carries a low voltage circuit and does not carry a high voltage circuit, wherein said circuit board portions (12a, 12b) are spaced apart from each other and one or more radiation detectors are mounted between said circuit board portions. (a) an array of sources of ionising radiation, (b) at least one detector probe for detecting ionising radiation comprising an array of radiation detectors mounted on a circuit board (12a, 12b), (c) a power source, and electronic apparatus comprising a control unit and a signal and data processing means for calculating a density profile of the material phases using signals generated by the detectors in response to radiation received from the radiation sources; the power source and electronic apparatus being housed within an enclosure supported mounted adjacent to the detector probe,
A process for producing a semifinished product for producing moldings made of a fiber-reinforced polymer, comprising the following steps: (i) inserting a fiber structure into a mold and injecting a polymer precursor compound around the fiber structure or saturating a fiber structure with a polymer precursor compound, where the viscosity of the polymer precursor compound is at most 2000 mPas, (ii) freezing the polymer precursor compound to obtain the semifinished product. (i) inserting a fiber structure into a mold and injecting a polymer precursor compound around the fiber structure or saturating a fiber structure with a polymer precursor compound, where the viscosity of the polymer precursor compound is at most 2000 mPas, (ii) freezing the polymer precursor compound to obtain the semifinished product.
A method for detecting the motion of a user or object in an elevator, the method comprising: measuring the acceleration experienced by the user or object to obtain a series of acceleration measurements; processing the series of acceleration measurements to identify a peak and a trough therein that are associated with the start and end of an elevator motion; identifying a section of the acceleration measurements corresponding to the elevator motion from the identified peak and trough; and determining an indication of the change in elevation of the user or object during the elevator motion from the identified section of the acceleration measurements. measuring the acceleration experienced by the user or object to obtain a series of acceleration measurements; processing the series of acceleration measurements to identify a peak and a trough therein that are associated with the start and end of an elevator motion; identifying a section of the acceleration measurements corresponding to the elevator motion from the identified peak and trough; and determining an indication of the change in elevation of the user or object during the elevator motion from the identified section of the acceleration measurements.
A method for wireless communication at a cell, comprising: determining an outside load based on a total load for the cell determined from a rise-over-thermal, RoT, measurement, an in-cell load for users served by the cell determined from uplink transmissions received from the users, and a non-serving active set load due to users in neighbor cells that have the cell in their active sets; determining an available load for a cell based on a target total load for the cell from a target RoT and the outside load; and scheduling users in the cell for transmission on uplink based on the available load for the cell; wherein the outside load is the load of users in other cells and not having the cell in their active sets. determining an outside load based on a total load for the cell determined from a rise-over-thermal, RoT, measurement, an in-cell load for users served by the cell determined from uplink transmissions received from the users, and a non-serving active set load due to users in neighbor cells that have the cell in their active sets; determining an available load for a cell based on a target total load for the cell from a target RoT and the outside load; and scheduling users in the cell for transmission on uplink based on the available load for the cell; wherein the outside load is the load of users in other cells and not having the cell in their active sets.